{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:39:36Z","timestamp":1785199176294,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["No.81902382"],"award-info":[{"award-number":["No.81902382"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the General Project of Natural Science Foundation of Liaoning Province","award":["No. 2022-MS-318"],"award-info":[{"award-number":["No. 2022-MS-318"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-024-01653-7","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T09:16:55Z","timestamp":1738574215000},"page":"2441-2452","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["FOXM1, a super enhancer-associated gene, is related to poorer prognosis and gemcitabine resistance in pancreatic cancer"],"prefix":"10.1007","volume":"83","author":[{"given":"Jian","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianci","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangning","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changmiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"key":"1653_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel, R. L., Miller, K. D., & Jemal, A. (2020). Cancer statistics, 2020. CA Cancer J. Clin., 70, 7\u201330.","journal-title":"CA Cancer J. Clin."},{"key":"1653_CR2","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/0092-8674(89)90133-5","volume":"57","author":"D Weigel","year":"1989","unstructured":"Weigel, D., J\u00fcrgens, G., K\u00fcttner, F., Seifert, E., & J\u00e4ckle, H. (1989). The homeotic gene fork head encodes a nuclear protein and is expressed in the terminal regions of the Drosophila embryo. Cell, 57, 645\u2013658.","journal-title":"Cell"},{"key":"1653_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.626836","volume":"10","author":"D Kalathil","year":"2021","unstructured":"Kalathil, D., John, S., & Nair, A. S. (2021). FOXM1 and cancer: faulty cellular signaling derails homeostasis. Front Oncol., 10, 626836.","journal-title":"Front Oncol."},{"key":"1653_CR4","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.3390\/cancers13123065","volume":"13","author":"C Liu","year":"2021","unstructured":"Liu, C., Barger, C. J., & Karpf, A. R. (2021). FOXM1: a multifunctional oncoprotein and emerging therapeutic target in ovarian cancer. Cancers, 13, 3065.","journal-title":"Cancers"},{"key":"1653_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215976","volume":"552","author":"W Zhang","year":"2023","unstructured":"Zhang, W., Qian, W., & Gu, J., et al. (2023). Mutant p53 driven-LINC00857, a protein scaffold between FOXM1 and deubiquitinase OTUB1, promotes the metastasis of pancreatic cancer. Cancer Lett., 552, 215976.","journal-title":"Cancer Lett."},{"key":"1653_CR6","first-page":"3644","volume":"12","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z., Liu, W., & Bao, X. et al. (2022). USP39 facilitates breast cancer cell proliferation through stabilization of FOXM1. Am. J. Cancer Res., 12, 3644\u20133661.","journal-title":"Am. J. Cancer Res."},{"key":"1653_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04960-0","volume":"13","author":"J Zhu","year":"2022","unstructured":"Zhu, J., Zhao, J., & Luo, C., et al.(2022). FAT10 promotes chemotherapeutic resistance in pancreatic cancer by inducing epithelial-mesenchymal transition via stabilization of FOXM1 expression. Cell Death Dis., 13, 497.","journal-title":"Cell Death Dis."},{"key":"1653_CR8","volume":"9","author":"H Madhi","year":"2022","unstructured":"Madhi, H., Lee, J. S., & Choi, Y. E., et al. (2022). FOXM1 inhibition enhances the therapeutic outcome of lung cancer immunotherapy by modulating PD-L1 expression and cell proliferation. Adv. Sci. (Weinh.), 9, e2202702.","journal-title":"Adv. Sci. (Weinh.)"},{"key":"1653_CR9","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1158\/1078-0432.CCR-22-0791","volume":"28","author":"S Guan","year":"2022","unstructured":"Guan, S., Chen, X., & Chen, Y. et al. (2022). FOXM1 variant contributes to gefitinib resistance via activating Wnt\/\u03b2-catenin signal pathway in patients with non-small cell lung cancer. Clin. Cancer Res., 28, 3770\u20133784.","journal-title":"Clin. Cancer Res."},{"key":"1653_CR10","doi-asserted-by":"publisher","first-page":"436.","DOI":"10.1186\/s13058-014-0436-4","volume":"16","author":"A Bergamaschi","year":"2014","unstructured":"Bergamaschi, A., Madak-Erdogan, Z., Kim, Y. J., Choi, Y. L., Lu, H. & Katzenellenbogen, B. S. (2014). The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells. Breast Cancer Res., 16, 436.","journal-title":"Breast Cancer Res."},{"key":"1653_CR11","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1038\/onc.2015.152","volume":"35","author":"F Zhao","year":"2016","unstructured":"Zhao, F., Monteiro, L. J. & Coombes, R. C. et al. (2016). Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance. Oncogene, 35, 990\u20131002.","journal-title":"Oncogene"},{"issue":"Sep 7","key":"1653_CR12","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/bjc.2017.292","volume":"117","author":"M Li","year":"2017","unstructured":"Li, M., Yang, J., & Zhou, W., et al. (2017). Activation of an AKT\/FOXM1\/STMN1 pathway drives resistance to tyrosine kinase inhibitors in lung cancer. Br. J. Cancer, 117(Sep 7), 974\u2013983.","journal-title":"Br. J. Cancer"},{"key":"1653_CR13","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1093\/carcin\/bgs167","volume":"33","author":"YY Park","year":"2012","unstructured":"Park, Y. Y., Jung, S. Y. & Jennings, N. B. et al. (2012). FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair. Carcinogenesis, 33, 1843\u20131853.","journal-title":"Carcinogenesis"},{"key":"1653_CR14","doi-asserted-by":"publisher","first-page":"5961","DOI":"10.1158\/1078-0432.CCR-12-0039","volume":"18","author":"N Zhang","year":"2012","unstructured":"Zhang, N., Wu, X. & Yang, L. et al. (2012). FoxM1 inhibition sensitizes resistant glioblastoma cells to temozolomide by downregulating the expression of DNA-repair gene Rad51. Clin. Cancer Res., 18, 5961\u20135971.","journal-title":"Clin. Cancer Res."},{"key":"1653_CR15","doi-asserted-by":"publisher","first-page":"108366.","DOI":"10.1016\/j.celrep.2020.108366","volume":"33","author":"MR Wilson","year":"2020","unstructured":"Wilson, M. R., Reske, J. J. & Holladay, J. et al. (2020). ARID1A mutations promote P300-dependent endometrial invasion through super-enhancer hyperacetylation. Cell Rep., 33, 108366.","journal-title":"Cell Rep."},{"key":"1653_CR16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.pharmthera.2019.02.014","volume":"199","author":"P Thandapani","year":"2019","unstructured":"Thandapani, P. (2019). Super-enhancers in cancer. Pharm. Ther., 199, 129\u2013138.","journal-title":"Pharm. Ther."},{"key":"1653_CR17","doi-asserted-by":"publisher","unstructured":"Gu, J., Gao, F. & Fan, B. et al. Correlation between macrophage polarization and PD-L1-related tumor microenvironmental alteration and metastasis in pancreatic ductal adenocarcinoma. J Oncol, https:\/\/doi.org\/10.1155\/2023\/7971306","DOI":"10.1155\/2023\/7971306"},{"key":"1653_CR18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.bbagrm.2011.09.004","volume":"1819","author":"CY Koo","year":"2012","unstructured":"Koo, C. Y., Muir, K. W., & Lam, E. W. (2012). FOXM1: From cancer initiation to progression and treatment. Biochim Biophys. Acta, 1819, 28\u201337.","journal-title":"Biochim Biophys. Acta"},{"key":"1653_CR19","doi-asserted-by":"publisher","first-page":"4329","DOI":"10.1158\/0008-5472.CAN-11-0640","volume":"71","author":"P Raychaudhuri","year":"2011","unstructured":"Raychaudhuri, P. & Park, H. J. (2011). FoxM1: a master regulator of tumor metastasis. Cancer Res., 71, 4329\u20134333.","journal-title":"Cancer Res."},{"key":"1653_CR20","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/MPA.0b013e31823bcef2","volume":"41","author":"JT Xia","year":"2012","unstructured":"Xia, J. T., Wang, H., & Liang, L. J. et al. (2012). Overexpression of FOXM1 is associated with poor prognosis and clinicopathologic stage of pancreatic ductal adenocarcinoma. Pancreas, 41, 629\u2013635.","journal-title":"Pancreas"},{"key":"1653_CR21","doi-asserted-by":"publisher","first-page":"5054","DOI":"10.1158\/0008-5472.CAN-10-0545","volume":"70","author":"JR Carr","year":"2010","unstructured":"Carr, J. R., Park, H. J., Wang, Z., Kiefer, M. M., & Raychaudhuri, P. (2010). FoxM1 mediates resistance to herceptin and paclitaxel. Cancer Res., 70, 5054\u20135063.","journal-title":"Cancer Res."},{"key":"1653_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.lungcan.2012.10.019","volume":"79","author":"Y Wang","year":"2013","unstructured":"Wang, Y., Wen, L., Zhao, S. H., Ai, Z. H., Guo, J. Z., & Liu, W. C. (2013). FoxM1 expression is significantly associated with cisplatin-based chemotherapy resistance and poor prognosis in advanced non-small cell lung cancer patients. Lung Cancer, 79, 173\u2013179.","journal-title":"Lung Cancer"},{"key":"1653_CR23","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/aps.2011.188","volume":"33","author":"N Xu","year":"2012","unstructured":"Xu, N., Zhang, X. & Wang, X. et al. (2012). FoxM1 mediated resistance to gefitinib in non-small-cell lung cancer cells. Acta Pharm. Sin., 33, 675\u2013681.","journal-title":"Acta Pharm. Sin."},{"key":"1653_CR24","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.bbrc.2014.11.039","volume":"457","author":"LY Wan","year":"2015","unstructured":"Wan, L. Y., Deng, J., & Xiang, X. J., et al. (2015). miR-320 enhances the sensitivity of human colon cancer cells to chemoradiotherapy in vitro by targeting FOXM1. Biochem Biophys. Res Commun., 457, 125\u2013132.","journal-title":"Biochem Biophys. Res Commun."},{"issue":"Mar 3","key":"1653_CR25","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.bbagrm.2014.11.008","volume":"1849","author":"CJ Hu","year":"2015","unstructured":"Hu, C. J., Wang, B., & Tang, B., et al. (2015). The FOXM1-induced resistance to oxaliplatin is partially mediated by its novel target gene Mcl-1 in gastric cancer cells. Biochim Biophys. Acta, 1849(Mar 3), 290\u2013299.","journal-title":"Biochim Biophys. Acta"},{"key":"1653_CR26","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1093\/abbs\/gmw072","volume":"48","author":"K Wang","year":"2016","unstructured":"Wang, K., Zhu, X., Zhang, K., Zhu, L. & Zhou, F. (2016). FoxM1 inhibition enhances chemosensitivity of docetaxel-resistant A549 cells to docetaxel via activation of JNK\/mitochondrial pathway. Acta Biochim Biophys. Sin. (Shanghai), 48, 804\u2013809.","journal-title":"Acta Biochim Biophys. Sin. (Shanghai)"},{"key":"1653_CR27","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1159\/000445653","volume":"39","author":"X Liu","year":"2016","unstructured":"Liu, X., Xie, T., Mao, X., Xue, L., Chu, X. & Chen, L. (2016). MicroRNA-149 increases the sensitivity of colorectal cancer cells to 5-fluorouracil by targeting forkhead box transcription factor FOXM1. Cell Physiol. Biochem, 39, 617\u2013629.","journal-title":"Cell Physiol. Biochem"},{"key":"1653_CR28","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1042\/CS20180816","volume":"133","author":"C Liu","year":"2019","unstructured":"Liu, C., Shi, J. & Li, Q. et al. (2019). STAT1-mediated inhibition of FOXM1 enhances gemcitabine sensitivity in pancreatic cancer.Clin. Sci. (Lond.), 133, 645\u2013663.","journal-title":"Clin. Sci. (Lond.)"},{"key":"1653_CR29","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1038\/s41467-021-24137-1","volume":"12","author":"J Dong","year":"2021","unstructured":"Dong, J., Li, J., Li, Y., Ma, Z., Yu, Y. & Wang, C. Y.(2021). Transcriptional super-enhancers control cancer stemness and metastasis genes in squamous cell carcinoma. Nat. Commun., 12, 3974","journal-title":"Nat. Commun."},{"key":"1653_CR30","doi-asserted-by":"publisher","first-page":"106940","DOI":"10.1016\/j.phrs.2023.106940","volume":"197","author":"M Tan","year":"2023","unstructured":"Tan, M., Pan, Q. & Gong, H. et al. (2023). Super-enhancer-associated SNHG15 cooperating with FOSL1 contributes to bladder cancer progression through the WNT pathway. Pharm. Res, 197, 106940","journal-title":"Pharm. Res"},{"key":"1653_CR31","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.cell.2014.10.024","volume":"159","author":"E Chipumuro","year":"2014","unstructured":"Chipumuro, E., Marco, E. & Christensen, C. L. et al. (2014). CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer. Cell, 159, 1126\u20131139.","journal-title":"Cell"},{"key":"1653_CR32","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.ccr.2013.11.003","volume":"24","author":"B Chapuy","year":"2013","unstructured":"Chapuy, B., McKeown, M. R. & Lin, C. Y. et al. (2013). Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma. Cancer Cell, 24, 777\u2013790. Erratum in: Cancer Cell. 2014 Apr 14;25(4):545-6.","journal-title":"Cancer Cell"},{"key":"1653_CR33","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","volume":"153","author":"J Lov\u00e9n","year":"2013","unstructured":"Lov\u00e9n, J., Hoke, H. A. & Lin, C. Y. et al. (2013). Selective inhibition of tumor oncogenes by disruption of super-enhancers.Cell, 153, 320\u2013334.","journal-title":"Cell"},{"key":"1653_CR34","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.celrep.2014.08.055","volume":"9","author":"R Di Micco","year":"2014","unstructured":"Di Micco, R., Fontanals-Cirera, B. & Low, V. et al. (2014). Control of embryonic stem cell identity by BRD4-dependent transcriptional elongation of super-enhancer-associated pluripotency genes. Cell Rep., 9, 234\u2013247.","journal-title":"Cell Rep."},{"key":"1653_CR35","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/nature09504","volume":"468","author":"P Filippakopoulos","year":"2010","unstructured":"Filippakopoulos, P., Qi, J. & Picaud, S. et al. (2010). Selective inhibition of BET bromodomains.Nature, 468, 1067\u20131073.","journal-title":"Nature"},{"key":"1653_CR36","doi-asserted-by":"publisher","first-page":"e2109133119","DOI":"10.1073\/pnas.2109133119","volume":"119","author":"B Liu","year":"2022","unstructured":"Liu, B., Liu, X. & Han, L. et al. (2022). BRD4-directed super-enhancer organization of transcription repression programs links to chemotherapeutic efficacy in breast cancer. Proc. Natl Acad. Sci., 119, e2109133119","journal-title":"Proc. Natl Acad. Sci."}],"updated-by":[{"DOI":"10.1007\/s12013-025-01710-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000}}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-024-01653-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-024-01653-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-024-01653-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T07:30:14Z","timestamp":1747639814000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-024-01653-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["1653"],"URL":"https:\/\/doi.org\/10.1007\/s12013-024-01653-7","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s12013-025-01710-9","asserted-by":"object"}]},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,3]]},"assertion":[{"value":"17 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The co-author Jiangning Gu\u2019s affiliation has been corrected.","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12013-025-01710-9","URL":"https:\/\/doi.org\/10.1007\/s12013-025-01710-9","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The inclusion of tissue microarrays from PDAC patients in this study were approved by the Ethics Committee of the First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China (PJ-KS-KY-2023-297).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}